Balaxi Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
BALAXI
Pharmaceuticals
Screen Balaxi Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹25.44
▼
-1.01 (-3.82%)
Market Cap
₹139.29 Cr.
P/E Ratio (TTM)
10.06
P/B Ratio
0.61
EPS (TTM)
₹4.54
Dividend Yield
-
Debt to Equity
0.17
52W High
₹77.94
52W Low
₹25.44
Operating Margin
16.00%
Profit Margin
12.00%
Revenue (TTM)
₹75.00
EBITDA
₹11.00
Net Income
₹9.00
Total Assets
₹310.00
Total Equity
₹232.00
Balaxi Pharmaceuticals Share Price History - Stock Screener Chart
Screen BALAXI historical share price movements with interactive charts. Analyze price trends and patterns.
Balaxi Pharmaceuticals Company Profile - Fundamental Screener
Screen Balaxi Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BALAXI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE618N01022
Balaxi Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BALAXI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 310 | 258 | 240 | 177 | 100 | 36 | 6 |
| Current Assets | 243 | 210 | 194 | 141 | 94 | 35 | 6 |
| Fixed Assets | 41 | 41 | 41 | 29 | 2 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 310 | 258 | 240 | 177 | 100 | 36 | 6 |
| Current Liabilities | 24 | 3 | 4 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 232 | 201 | 183 | 113 | 65 | 28 | 4 |
| Share Capital | 11 | 11 | 10 | 10 | 10 | 10 | 3 |
| Reserves & Surplus | 221 | 187 | 162 | 103 | 55 | 18 | 1 |
Screen BALAXI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75 | 69 | 58 | 59 | 64 | 73 | 77 | 81 | 65 | 61 | 62 | 93 | 86 | 91 | 82 |
| Expenses | 64 | 67 | 55 | 46 | 56 | 67 | 69 | 68 | 104 | 44 | 47 | 78 | 69 | 72 | 71 |
| EBITDA | 11 | 2 | 3 | 13 | 8 | 7 | 8 | 13 | -39 | 17 | 15 | 15 | 17 | 19 | 11 |
| Operating Profit % | 16.00% | 6.00% | 2.00% | 23.00% | 15.00% | 14.00% | 5.00% | 16.00% | -57.00% | 20.00% | 22.00% | 13.00% | 17.00% | 17.00% | 18.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 1 | 1 | 12 | 7 | 6 | 6 | 11 | -39 | 16 | 14 | 15 | 17 | 19 | 11 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 1 | 2 | 3 | 3 | 2 |
| Net Profit | 9 | 0 | 0 | 11 | 7 | 5 | 5 | 8 | -41 | 14 | 14 | 13 | 14 | 16 | 8 |
| EPS | 1.56 | 0.05 | 0.04 | 10.41 | 1.17 | 0.84 | 0.97 | 8.01 | -40.49 | 14.10 | 13.29 | 12.71 | 14.15 | 15.49 | 8.21 |
Balaxi Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen BALAXI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -35 | 5 | 6 | 34 | 0 | -14 | -2 |
| Investing Activities | -22 | -1 | -11 | -29 | -6 | 0 | 0 |
| Financing Activities | 34 | 30 | 26 | 0 | 4 | 18 | 0 |
| Net Cash Flow | -23 | 34 | 21 | 6 | -2 | 4 | -2 |
Screen BALAXI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Apr | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 65.99% | 65.99% | 65.99% | 66.36% | 66.36% | 65.99% | 65.99% | 65.99% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.82% | 16.14% | 20.03% | 7.98% | 7.98% | 8.60% | 9.24% | 9.69% |
| Other Holding | 24.17% | 17.84% | 13.95% | 25.64% | 25.64% | 25.38% | 24.74% | 24.29% |
| Shareholder Count | 9,994 | 13,737 | 14,620 | 5,132 | 5,132 | 6,586 | 7,863 | 8,529 |
Balaxi Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen BALAXI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.50 | 0.47% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Balaxi Pharmaceuticals Index Membership - Market Screener Classification
Screen BALAXI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Balaxi Pharmaceuticals Market Events Screener - Corporate Actions
Screen BALAXI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -3.16% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -3.91% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -6.82% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.44% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | -1.03% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -5.24% |
| 2024-05-30 | 2024-02-28 | Split | 2:10 | 0.00% |
| 2022-07-01 | 2022-07-04 | Dividend | ₹ 0.50 /share | -13.13% |
| 2020-10-07 | 2020-10-07 | Change Of Name | NA | 0.00% |
Balaxi Pharmaceuticals Competitors Screener - Peer Comparison
Screen BALAXI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,725 | 40.31 | 54,729 | 9.71% | 10,980 | 52.13 |
| Divis Laboratories | 175,408 | 70.47 | 9,712 | 18.67% | 2,191 | 59.83 |
| Torrent Pharmaceuticals | 134,498 | 63.66 | 11,539 | 6.99% | 1,911 | 70.17 |
| Cipla | 118,274 | 21.71 | 28,410 | 7.12% | 5,291 | 36.98 |
| Dr Reddys Laboratories | 101,124 | 17.57 | 33,741 | 16.73% | 5,725 | 29.23 |
| Lupin | 99,578 | 23.02 | 22,910 | 13.74% | 3,306 | 65.89 |
| Mankind Pharma | 91,251 | 52.52 | 12,744 | 20.90% | 2,007 | 56.26 |
| Zydus Life Science | 89,882 | 18.16 | 23,511 | 18.55% | 4,615 | 41.07 |
| Aurobindo Pharma | 69,342 | 20.49 | 32,346 | 9.43% | 3,484 | 51.02 |
| Alkem Laboratories | 69,127 | 28.76 | 13,458 | 3.70% | 2,216 | 62.82 |
Balaxi Pharmaceuticals Company Announcements - News Screener
Screen BALAXI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-12-29 | Trading Window | View |
| 2025-11-14 | Investor Presentation | View |
| 2025-11-14 | Credit Rating | View |
| 2025-11-12 | Copy of Newspaper Publication | View |
| 2025-11-11 | Updates | View |
| 2025-11-11 | Statement of deviation(s) or variation(s) under Reg. 32 | View |
| 2025-11-11 | Outcome of Board Meeting | View |
| 2025-10-08 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-09-29 | Trading Window | View |